Guanadrel sulfate: a postganglionic sympathetic inhibitor for the treatment of mild to moderate hypertension.
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006145:Guanethidine / Q000627:therapeutic use; D006146:Guanidines / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007700:Kinetics; D008750:Methyldopa / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D006146:Guanidines; D013565:Sympatholytics; D008750:Methyldopa; C004945:guanadrel; D006145:Guanethidine